RegWardenFDA facility compliance records
Company

RefleXion Medical, Inc.

4 recall(s) on record — most severe on record: Class II.

Recalls by year

FDA actions on record by year2021: 1 recalls; 2024: 1 recalls; 2025: 1 recalls; 2026: 1 recalls20172018201920201202120222023120241202512026
  • Recalls (4)

Registered facilities (1)

Recalls & enforcement

  • Class IIOngoing2026-02-09
    Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being d…
  • Class IIOngoing2025-07-22
    Due to incorrect software configuration that potentially allows more than two (2) fractions within a 12-hour period (fractionLimits) and could potentially lead to adverse events (toxicity).
  • Class IIOngoing2024-04-16
    A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.
  • Class IITerminated2021-11-24
    Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. We restate the public record only — measured facts, never risk verdicts.

Cite this record

RegWarden. “RefleXion Medical, Inc. — FDA compliance profile.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/company/oo-10078251-reflexion-medical-inc/

Not open yet

Alerts for RefleXion Medical, Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.